Safety and Efficacy of Inhaled Insulin in Patients With Diabetes and Asthma or COPD

Clinical trial NCT00157339 · COMPLETED

Trial details

NCT number: NCT00157339
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Diabetes Mellitus Asthma Pulmonary Disease, Chronic Obstructive

Start date: 2005-08-01
Primary completion: 2008-05-01
Enrollment: 299

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.